Chazal, N; Singer, G; Aiken, C et al. (2001) Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J Virol 75:4014-8
|
Scoggins, R M; Taylor Jr, J R; Patrie, J et al. (2000) Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J Virol 74:3205-16
|
Hamm, T E; Rekosh, D; Hammarskjold, M L (1999) Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 protein. J Virol 73:5741-7
|
Helga-Maria, C; Hammarskjold, M L; Rekosh, D (1999) An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA. J Virol 73:4127-35
|
Srinivasakumar, N; Chazal, N; Helga-Maria, C et al. (1997) The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J Virol 71:5841-8
|
Pasquinelli, A E; Ernst, R K; Lund, E et al. (1997) The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J 16:7500-10
|